Test oral aroeira for long-term indigestion versus omeprazole
Treatments studied
Part of Digestive system clinical trials.
This trial compares an herbal medicine (oral aroeira) to omeprazole, a common acid-reducing medicine, for people with long-lasting indigestion symptoms. It may help find out whether aroeira works as well as (or better than) omeprazole for relieving symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have at least one indigestion symptom (nausea, heartburn, upper belly pain, bloating/discomfort with meals, or feeling full quickly).
- Your symptoms started more than 6 months ago and have been present for at least 3 months.
- You can and agree to take part freely after understanding the study (informed consent).
- You’re between 18 and 80 years old.
- If you can get pregnant, you can use an approved birth-control method during the study and until the final visit (and meet the study’s requirements).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how well omeprazole (a common acid-blocking medicine) works for people with laryngopharyngeal reflux (LPR), a condition where stomach acid irritates the throat. If you have had throat symptoms for more than 8 weeks and are already scheduled for an endoscopy with acid monitoring, you may qualify to see if this medicine helps more than a placebo.
This trial tests a new medicine called anaprazole for people with moderate to severe reflux esophagitis (chronic heartburn and damage to the food pipe). It compares anaprazole to a standard treatment to see which works better and is safer.
This trial tests whether a new liquid antacid (Antareit) works as well as the chewable Riopan tablets in healthy people. It involves a small tube placed through your nose to measure stomach acid before and after taking the medication.
This study tests whether a probiotic called Lactobacillus rhamnosus GG can improve gut bacteria changes caused by proton pump inhibitors (acid-reducing medicines). It mainly involves people who are otherwise healthy and do not currently have ongoing stomach or gut symptoms.
This trial tests two medications, acotiamide and itopride, to see which one better relieves symptoms like fullness and bloating after eating. It is for people diagnosed with postprandial distress syndrome (a type of functional dyspepsia).
This trial tests vonaprazan (two doses) against esomeprazole to see which better heals moderate-to-severe reflux esophagitis (a damaged esophagus from acid reflux) in 8 weeks. You may qualify if you have had heartburn or regurgitation for at least a month and your doctor found grade B, C, or D damage on an endoscopy.
Hear when a new Dyspepsia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.